My Cart

CD16a

CD16a Product List

  • Product Category

    Antibody (2)Cell (1)

  • Product Status

    Launched (3)

  • Species

    Mouse (2)Human (1)

  • Tag

    - (3)

  • Conjugate

    PE Labeled (1)APC Labeled (1)- (1)

CD16a Background

CD16 encodes a receptor that recognizes the Fc portion of immunoglobulin G and is involved in the clearance of immune complexes from the circulation, as well as other functions such as cellular mediated cytotoxicity and enhancement of virus infections. This gene, FCGR3A, shares a high degree of similarity with another nearby gene, FCGR3B, located on chromosome 1. The receptor encoded by this gene is expressed on natural killer (NK) cells as an integral membrane glycoprotein anchored through a transmembrane peptide, while FCGR3B is expressed on polymorphonuclear neutrophils (PMN) where the receptor is anchored through a phosphatidylinositol (PI) linkage. Mutations in this gene have been associated with immunodeficiency 20 and have been linked to susceptibility to recurrent viral infections, susceptibility to systemic lupus erythematosus, and alloimmune neonatal neutropenia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. Diseases associated with FCGR3A include Immunodeficiency 20 and Herpes Zoster.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
SiplizumabMEDI-507; TCD-601Phase 2 ClinicalCatholic University Of Louvain, Itb-Med LlcMultiple Myeloma; Amyotrophic Lateral Sclerosis; Kidney Failure, Chronic; Plaque psoriasis; Anemia, Sickle Cell; Lymphoma; Lymphoma, T-Cell; Hidradenitis Suppurativa; Hepatitis, Autoimmune; Lymphoma, Extranodal NK-T-Cell; Psoriasis; Cholangitis, Sclerosing; Diabetes Mellitus, Type 1; Liver Diseases; Myelodysplastic Syndromes; Neoplasms; Graft vs Host Disease; Kidney Diseases; Liver Cirrhosis; Renal Insufficiency; Rejection of liver transplantation; Leukemia; End Stage Liver Disease; Rejection of renal transplantation
Details
AlefaceptLFA-3-TIP; LFA-3(92)IgG; BG-9273; BG-9712; ASP-0485Phase 1 ClinicalAstellas Pharma IncDiabetes Mellitus, Type 1; Graft vs Host Disease; Psoriasis; Anemia, Aplastic; Lymphoma
Details
SBT-11-5301SBT115301Phase 1 ClinicalSonoma Biotherapeutics IncAutoimmune Diseases
Details
PIT-565PIT-565Phase 1 ClinicalNovartis Pharma AgLymphoma, B-Cell; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Lupus Erythematosus, Systemic; Leukemia, Myeloid, Acute
Details
  • Product List
  • Clinical Drug Information